Closed
SectorHealthcare
20.59 3.31
24h
Min
19.93
Max
20.64
Income | -85M 27M |
---|---|
Sales | -2.7M 115M |
P/E Sector Avg | 24.357 51.198 |
EPS | 0.136 |
Profit margin | 23.435 |
Employees | 685 |
EBITDA | -4.7M 35M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +53.81% upside |
Next Earnings | 7 sie 2025 |
---|
Market Cap | 1.1B 4.9B |
---|---|
Previous open | 17.28 |
Previous close | 20.59 |
By Acuity
16%
84%
26 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 30.67 USD 53.81%
High 35 USD
Low 25 USD
Based on 3 Wall Street analysts offering 12 month price targets forADMA Biologics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$